Development of an Ovarian Neoplasm

Description

Anterior pelvic anatomy is rendered with the uterus centered in the midline, the cervix continuous inferiorly with the vaginal canal, and paired uterine (fallopian) tubes extending superolaterally to the ovaries. One ovary is enlarged by an irregular intraovarian mass consistent with malignant neoplastic proliferation, expanding the ovarian cortex and distorting the normal ovoid contour while remaining lateral to the uterine fundus. The fimbrial end of the tube approaches the ovarian surface, a close relationship that matters when considering tubal versus ovarian origin of epithelial carcinoma. Serosal surfaces and adjacent adnexal anatomy remain legible for orientation. Ovarian carcinoma often presents late because early growth can remain confined to the adnexa with minimal mass effect on the uterus or cervix, so a depiction that anchors the tumor to the ovary while keeping the rest of the reproductive tract in standard anatomic position helps teach why symptoms are vague and why pelvic exam may be unrevealing. Many high grade serous carcinomas arise from the distal tube (fimbriae) and then involve the ovary secondarily, so the juxtaposition of the fimbria and ovarian surface supports discussions of current pathogenesis models, staging workup, and the rationale for opportunistic salpingectomy. Spread by transcoelomic exfoliation to peritoneum and omentum, and lymphatic dissemination to pelvic and para-aortic nodes, can be introduced from this starting point. Subtle beginnings. Big consequences. Use this artwork for gynecologic oncology lectures on adnexal masses, epithelial ovarian cancer staging (FIGO), and operative planning for salpingo-oophorectomy with hysterectomy, as well as for patient-facing materials explaining where an ovarian neoplasm grows relative to the uterus and tubes. It also fits pathology and radiology teaching when paired with ultrasound or CT correlations of an enlarged, complex adnexal mass. Anatomical accuracy verified by SciePro's Medical Advisory Board.